Previous close | 14.43 |
Open | 14.35 |
Bid | 14.12 x 4000 |
Ask | 14.13 x 3100 |
Day's range | 13.97 - 14.41 |
52-week range | 7.09 - 14.45 |
Volume | |
Avg. volume | 11,008,891 |
Market cap | 15.817B |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.50 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 27 Nov 2017 |
1y target est | 15.13 |
Bausch (BHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Key Insights Given the large stake in the stock by institutions, Teva Pharmaceutical Industries' stock price might be...
Corcept (CORT) expects its sole marketed drug, Korlym, approved for treating Cushing's syndrome, to generate incremental sales and combat stiff competition.